N-<(1S)-1-(Ethoxycarbonyl)-3-Phenylpropyl>-L-Alanyl-L-Proline Benzylester置于palladium On Activated Charcoal 氢气体系中,用 乙醇 作为反应溶剂,化学反应 2.0H,反应生成 依那普利 参考文献:Studies On Angiotensin Converting Enzyme Inhibitors. V. The Diastereoselective Synthesis Of 2-Oxoimidazolidine Derivatives. 标题:Studies On Angiotensin Converting Enzyme Inhibitors. V. The Diastereoselective Synthesis Of 2-Oxoimidazolidine Derivatives. 摘要:建立了一种具有二面体选择性的imidapril(1)合成方法,该药物正在进行临床研究,作为一种基于其血管紧张素转化酶(ace)抑制活性的抗高血压药物.将(2S)-2-Amino-4-Phenylbutyric Acid Ester(12)与3-((2R)-2-甲基或甲苯磺酰氧丙酰)-2-氧代咪唑烷衍生物(11)通过sn2方式进行n-烷基化,选择性地反应生成叔丁基(4S)-3-[(2S)-2-[n-[(1S)-1-乙氧基碳酰基)-3-苯基丙基]氨基]丙酰]-1-甲基-2-氧代咪唑烷-4-羧酸酯(13),该化合物是1的前体.作为替代,合成了苄基(2S)-2-[n-(1S)-1-(乙氧基碳酰基)-3-苯基丙基]氨基]丙酸酯(15),这是13的关键构件.该程序也应用于enalapril的合成. DOI:10.1248/cpb.39.1374
专利号:US-9353057-B2 优先权日:2003-12-30 标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof 发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA 权利人:XENOPORT INC 摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.
专利号:US-7169589-B2 优先权日:2000-07-28 标题 :Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof 发明人:MUELLER WERNER E G; SCHROEDER HEINZ C; LORENZ BERND; KRASKO ANATOLI 权利人:MUELLER WERNER E G; SCHROEDER HEINZ C; LORENZ BERND; KRASKO ANATOLI 摘要:Silicatein is an enzyme of silicate-forming organisms used for the synthesis of their silicate scaffold. The present invention relates to the use of highly-expressed and highly active recombinant silicatein, silicatein isolated from natural sources after gene induction as well as silicatein-fusion proteins for the synthesis of amorphous silicon dioxide (silicic acids and silicates), siloxanes as well as modification of these compounds and their technical use.
专利号:US-10925977-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications 发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S 权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS 摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
专利号:US-10973847-B2 优先权日:2017-06-30 标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof 发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.
专利号:US-10005720-B2 优先权日:2013-04-05 标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same 发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L 权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL 摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.
专利号:US-7094920-B2 优先权日:2001-05-21 标 题 :Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters 发明人:TIKARE RAVEENDRA KHANDURAO 权利人:FERMENTA BIOTECH LTD 摘要:A process is described for the stereospecific preparation of an ester of formula (I): wherein * signifies the (R) stereoisomer; R 1 is selected from C 1-6 alkyl, preferably ethyl; and R 2 is hydrogen, a protecting group or a leaving group which process comprises reaction of a nitrile of formula (II): wherein * signifies the (R) stereoisonomer; and Ph is the phenyl group C 6 H 5 with a solution of an inorganic acid in an alcohol and optional conversion of the compound of formula (I) wherein R 2 is H so prepared to any other desired compound of formula (I) by standard methods in the art. The compounds of formula (I) are chiral esters, useful as intermediates in the synthesis of the family of acetylcholine esterase (ACE) inhibitors known as “prilsâ€?, such as lisinopril, cilazapril, enalapril, benazepril, ramipril, delapril, enalaprilat, imidapril, spirapril, trandolapril and others.n n*n nPh-CH 2 —CH 2 —CH(OR 2 )—COOR 1   (I)n n*n nPh-CH 2 —CH 2 —CH(H)—CN  (II)
1: Moffett BS, DiSanto AR, Espinosa O, Hou J, Colabuono P. Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets. Clin Pharmacol Drug Dev. 2014 Nov;3(6):493-8. doi: 10.1002/cpdd.129. Epub 2014 Jun 27. doi: 10.1016/j.rvsc.2014.06.006. Epub 2014 Jun 12. doi: 10.1111/jphp.12471. Epub 2015 Aug 10. doi: 10.1111/bcp.12667. Epub 2015 Jun 11. 5: Maldonado J, Pereira T, Tavares A. Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal. Drugs R D. 2014 Jun;14(2):147-54. doi: 10.1007/s40268-014-0046-8. 6: CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987 Jun 4;316(23):1429-35. doi: 10.1016/j.rvsc.2014.01.006. Epub 2014 Feb 3. German. doi: 10.1002/bmc.3201. Epub 2014 May 2. Epub 2016 Jul 19. Erratum in: N Engl J Med 1992 Dec 10;327(24):1768. doi: 10.1002/bmc.1716. Epub 2011 Sep 23. eCollection 2016. Review.
合成参考文献
参考文献:10.2165/11531660-000000000-00000 摘要:Merli M, Bragazzi MC, Giubilo F, Callea F, Attili AF, Alvaro D. Atorvastatin-induced prolonged cholestasis with bile duct damage. Clin Drug Investig. 2010;30(3):205–9. doi: 10.2165/11531660-000000000-00000. 参考文献:10.1007/s00467-009-1434-0 摘要:Caletti MG, Balestracci A, Roy AH. Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome. Pediatr Nephrol. 2010 Jun;25(6):1177–80. doi: 10.1007/s00467-009-1434-0. 参考文献:10.4061/2011/132405 摘要:Tedla FM, Brar A, Browne R, Brown C. Hypertension in Chronic Kidney Disease: Navigating the Evidence. International Journal of Hypertension. 2011;2011():1–9. doi: 10.4061/2011/132405. 参考文献:10.4061/2011/346985 摘要:Essick EE, Sam F. Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor. International Journal of Hypertension. 2011;2011():1–12. doi: 10.4061/2011/346985. 参考文献:10.4061/2011/417594 摘要:Demede M, Pandey A, Innasimuthu L, Jean-Louis G, McFarlane SI, Ogedegbe G. Management of Hypertension in High-Risk Ethnic Minority with Heart Failure. International Journal of Hypertension. 2011;2011():1–8. doi: 10.4061/2011/417594.